Sean Carroll has joined executive search firm Polachi & Co. as a Stamford, Conn.-based partner, with a focus on C-level tech executives. He previously was a managing partner with the Barlow Group, and before that was with both Pequot Capital's venture capital unit and Heidrick & Struggles.
The Carlyle Group has agreed to buy OpenLink Financial from TA Associates. No financial terms were disclosed for the deal, which is expected to close later this quarter. Bank of America Securities and Credit Suisse Securities are providing leveraged financing. OpenLink is a Long Island-based provider of software for the the commodity, energy and financial services industries.
Milestone Partners has completed a refinancing of portfolio company Good Health Natural Products, a Greensboro, N.C.-based maker of branded reduced-fat salty snack foods. No financial terms were disclosed for the deal, which included participation by Salem Halifax Capital Partners and the Morgan Keegan Strategic Fund.
Lantiq, a portfolio company of Golden Gate Capital, has acquired the wireline business of Infineon Technologies AG (Frankfurt: IFX), for approximately €243 million.
Advent International has made a public tender offer to acquire Polish educational publisher Wydawnictwa Szkolne i Pedagogiczne SA (WSiP). The offer is valued just north of $142 million.
AT&T has completed its acquisition of rural phone company Centennial Communications Corp. (Nasdaq: CYCL). The deal was valued at $944 million in cash, or $8.50 per share. Welsh Carson Anderson & Stowe was Centennial’s largest shareholder, and has agreed to support the deal.
STR Holdings Inc., an Enfield, Conn.-based maker of solar power module encapsulants, raised $123 million in its IPO. The company priced 12.3 million common shares at $10 per share (below $13-$15 offering range), and closed its first day of trading at $13.10 per share. Credit Suisse and Goldman Sachs served as co-lead underwriters on the IPO. […]
China Investment Corp. has agreed to buy $1.58 billion of new equity in U.S. power generation and distribution company The AES Corp. (NYSE: AES), in exchange for around a 15% ownership position.
Graceway Pharmaceuticals LLC, a portfolio company of GTCR Golder Rauner, has acquired the global license to an anti-proliferative agent from Gilead Sciences. The investigational molecule is designed to inhibit cellular DNA synthesis, leading to the induction of apoptosis. No financial terms were disclosed.
The Quercus Trust has completed its acquisition of Applied Solar Inc., a maker of building-integrated photovoltaics that filed for bankruptcy earlier this year.